These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 31777044

  • 1. Cerebral Insufficiency Caused by Diazoxide in a Premature Neonate with Congenital Hyperinsulinism.
    Okada S, Fukunaga S, Ohta H, Furuta T, Hirano R, Motonaga T, Ishikawa Y.
    Neuropediatrics; 2020 Jun; 51(3):211-214. PubMed ID: 31777044
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.
    Herrera A, Vajravelu ME, Givler S, Mitteer L, Avitabile CM, Lord K, De León DD.
    J Clin Endocrinol Metab; 2018 Dec 01; 103(12):4365-4372. PubMed ID: 30247666
    [Abstract] [Full Text] [Related]

  • 3. Necrotizing Enterocolitis in Neonates With Hyperinsulinemic Hypoglycemia Treated With Diazoxide.
    Keyes ML, Healy H, Sparger KA, Orth LE, Geha M, Roumiantsev S, Matute JD.
    Pediatrics; 2021 Feb 01; 147(2):. PubMed ID: 33483452
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant.
    Ohnishi Y, Okada S, Yasudo H, Kimura S, Suzuki Y, Hasegawa S.
    Int Heart J; 2020 Sep 29; 61(5):1084-1087. PubMed ID: 32921661
    [Abstract] [Full Text] [Related]

  • 5. High prevalence of severe circulatory complications with diazoxide in premature infants.
    Yoshida K, Kawai M, Marumo C, Kanazawa H, Matsukura T, Kusuda S, Yorifuji T, Heike T.
    Neonatology; 2014 Sep 29; 105(3):166-71. PubMed ID: 24458138
    [Abstract] [Full Text] [Related]

  • 6. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
    Taylor-Miller T, Houghton J, Munyard P, Kumar Y, Puvirajasinghe C, Giri D.
    J Pediatr Endocrinol Metab; 2020 May 26; 33(5):671-674. PubMed ID: 32267248
    [Abstract] [Full Text] [Related]

  • 7. Diazoxide toxicity in a child with persistent hyperinsulinemic hypoglycemia of infancy: mixed hyperglycemic hyperosmolar coma and ketoacidosis.
    Mangla P, Hussain K, Ellard S, Flanagan SE, Bhatia V.
    J Pediatr Endocrinol Metab; 2018 Aug 28; 31(8):943-945. PubMed ID: 29958183
    [Abstract] [Full Text] [Related]

  • 8. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism.
    Malhotra N, Yau D, Cunjamalay A, Gunasekara B, S A, Gilbert C, Morgan K, Dattani M, Dastamani A.
    Clin Endocrinol (Oxf); 2024 Feb 28; 100(2):132-137. PubMed ID: 38059644
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The treatment effect of diazoxide on 44 patients with congenital hyperinsulinism.
    Hu S, Xu Z, Yan J, Liu M, Sun B, Li W, Sang Y.
    J Pediatr Endocrinol Metab; 2012 Feb 28; 25(11-12):1119-22. PubMed ID: 23329758
    [Abstract] [Full Text] [Related]

  • 11. Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.
    Timlin MR, Black AB, Delaney HM, Matos RI, Percival CS.
    Pediatr Cardiol; 2017 Aug 28; 38(6):1247-1250. PubMed ID: 28642988
    [Abstract] [Full Text] [Related]

  • 12. Case report: A novel HNF1A variant linked to gestational diabetes, congenital hyperinsulinism, and diazoxide hypersensitivity.
    Chandran S, Verma D, Rajadurai VS, Yap F.
    Front Endocrinol (Lausanne); 2024 Aug 28; 15():1471596. PubMed ID: 39421536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis.
    Chen X, Feng L, Yao H, Yang L, Qin Y.
    PLoS One; 2021 Aug 28; 16(2):e0246463. PubMed ID: 33571197
    [Abstract] [Full Text] [Related]

  • 15. Liver injury may increase the risk of diazoxide toxicity: a case report.
    Tas E, Mahmood B, Garibaldi L, Sperling M.
    Eur J Pediatr; 2015 Mar 28; 174(3):403-6. PubMed ID: 25618267
    [Abstract] [Full Text] [Related]

  • 16. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom.
    Chen SC, Dastamani A, Pintus D, Yau D, Aftab S, Bath L, Swinburne C, Hunter L, Giardini A, Christov G, Senniappan S, Banerjee I, Shaikh MG, Shah P.
    Clin Endocrinol (Oxf); 2019 Dec 28; 91(6):770-775. PubMed ID: 31520536
    [Abstract] [Full Text] [Related]

  • 17. Development of pulmonary hypertension in an infant treated with diazoxide.
    Nebesio TD, Hoover WC, Caldwell RL, Nitu ME, Eugster EA.
    J Pediatr Endocrinol Metab; 2007 Aug 28; 20(8):939-44. PubMed ID: 17937066
    [Abstract] [Full Text] [Related]

  • 18. Pericardial Effusion Associated with Diazoxide Treatment for Congenital Hyperinsulinism.
    Hastings LA, Preddy J, McCready M, Neville K, Verge CF.
    Horm Res Paediatr; 2020 Aug 28; 93(3):206-211. PubMed ID: 32580193
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A case of severe diazoxide toxicity.
    Silvani P, Camporesi A, Mandelli A, Wolfler A, Salvo I.
    Paediatr Anaesth; 2004 Jul 28; 14(7):607-9. PubMed ID: 15200661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.